- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Kerala keen on affordable drug manufacturing
Kerala minister says he is open to investment in drug manufacturing estimated to be a 1000 crore market in the statePK Kunhalikutty, a state minister in Kerala is keen to sanction a study to explore the potential for drug manufacturing companies in the state. PK has shared his comments on the estimated size of the drugs market to be 1000 crore in Kerala.With a sole objective to...
PK Kunhalikutty, a state minister in Kerala is keen to sanction a study to explore the potential for drug manufacturing companies in the state. PK has shared his comments on the estimated size of the drugs market to be 1000 crore in Kerala.
With a sole objective to introduce affordable drugs for all, the state minister has expressed interest in associating with mini-ratna company HLL Life Care ltd , headquartered in the capital city. As reported by IANS, the company is in the process of implementing a Rs 594 crore integrated vaccines project at Chengalpet near Chennai.
The state owned Kerala State Drugs and Pharmaceuticals currently manufactures drugs in the state. However, PK has expressed concern over the slow process of manufacturing at the firm citing culture reasons. The minister is of the opinion that with time there are new and easy ways to manufacture medicines now.
Meghna A Singhania is the founder and Editor-in-Chief at Medical Dialogues. An Economics graduate from Delhi University and a post graduate from London School of Economics and Political Science, her key research interest lies in health economics, and policy making in health and medical sector in the country.She is a member of the Association of Healthcare Journalists. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751